Search research articles
Contact Us
Filters
Showing results (61-70 of 156) with videos related to
Page
of 16
Sort By:
Journal of Asthma and Allergy
|
June 24, 2022
Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses
David M G Halpin, Adrian Paul Rabe, Wei Jie Loke, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
July 18, 2002
Feasibility and effectiveness of a pulmonary rehabilitation programme in a community hospital setting
Janet A Ward, Gill Akers, David G Ward, et al.
Respiratory Research
|
October 7, 2018
Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
Donald P Tashkin, Marc Miravitlles, Bartolomé R Celli, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 8, 2026
Moving to better COPD care-changes to and challenges for GOLD
Claus F Vogelmeier, David M G Halpin, Gerard J Criner, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 14, 2015
The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial
Pierluigi Paggiaro, David M G Halpin, Roland Buhl, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
October 17, 2008
Guidelines versus practice: UK asthma nurses often recommend intermittent, symptom-driven use of inhaled corticosteroids
Michael E Hyland, Sue Blake, Colin J Greaves, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
June 21, 2011
A randomised controlled trial of the effect of automated interactive calling combined with a health risk forecast on frequency and severity of exacerbations of COPD assessed clinically and using EXACT PRO
David M G Halpin, Tish Laing-Morton, Sarah Spedding, et al.
Respiratory Research
|
July 11, 2020
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
Klaus F Rabe, David M G Halpin, MeiLan K Han, et al.
Advances in Therapy
|
April 2, 2023
A Response to: Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis"
Afisi S Ismaila, Katrin Haeussler, Mia Malmenäs, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 12, 2025
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK
Rui Cai, Alan A Martin, Yuchen Ge, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 156) with videos related to
Sort By:
Page
of 16
Journal of Asthma and Allergy
|
June 24, 2022
Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses
David M G Halpin, Adrian Paul Rabe, Wei Jie Loke, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
July 18, 2002
Feasibility and effectiveness of a pulmonary rehabilitation programme in a community hospital setting
Janet A Ward, Gill Akers, David G Ward, et al.
Respiratory Research
|
October 7, 2018
Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
Donald P Tashkin, Marc Miravitlles, Bartolomé R Celli, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 8, 2026
Moving to better COPD care-changes to and challenges for GOLD
Claus F Vogelmeier, David M G Halpin, Gerard J Criner, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 14, 2015
The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial
Pierluigi Paggiaro, David M G Halpin, Roland Buhl, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
October 17, 2008
Guidelines versus practice: UK asthma nurses often recommend intermittent, symptom-driven use of inhaled corticosteroids
Michael E Hyland, Sue Blake, Colin J Greaves, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
June 21, 2011
A randomised controlled trial of the effect of automated interactive calling combined with a health risk forecast on frequency and severity of exacerbations of COPD assessed clinically and using EXACT PRO
David M G Halpin, Tish Laing-Morton, Sarah Spedding, et al.
Respiratory Research
|
July 11, 2020
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
Klaus F Rabe, David M G Halpin, MeiLan K Han, et al.
Advances in Therapy
|
April 2, 2023
A Response to: Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis"
Afisi S Ismaila, Katrin Haeussler, Mia Malmenäs, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 12, 2025
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK
Rui Cai, Alan A Martin, Yuchen Ge, et al.
Page
of 16